Publicado 26/10/2015 09:01
- Comunicado -

Janssen Receives Positive CHMP Opinion Recommending EDURANT®▼ (rilpivirine) for the Treatment of Adolescents Aged 12 to

[2] World Health Organization. (2013). HIV and adolescents: Guidance for HIV testing and counselling and care for adolescents living with HIV Guidance document. [Online]. Available at http://www.who.int/hiv/pub/guidelines/ad.... Last accessed October 2015.

[3] Lombaard J, et al. 8th IAS 2015. (2015). [Abstract MOAB0106] Week 48 safety and efficacy of a rilpivirine (TMC278)-based regimen in HIV-infected treatment-naive adolescents: PAINT phase II trial. Available upon request.

[4] World Health Organization. (2013). Global summary of the AIDS epidemic. Available at http://www.who.int/gho/hiv/en. [Online]. Last accessed October 2015.

[5] UNAIDS. (2013). Global report factsheet. [Online]. Available at: http://www.unaids.org/en/resources/campa.... Last accessed October 2015.

[6] World Health Organization. (2013). HIV and Adolescents: Guidance for HIV Testing and Counselling and Care for Adolescents Living with HIV: Recommendations for a Public Health Approach and Considerations for Policy-Makers and Managers. [Online]. Available at: http://www.ncbi.nlm.nih.gov/books/NBK217.... Last accessed October 2015.

[7] World Health Organization Europe. (2015). HIV/AIDS Data and statistics. [Online]. Available at: http://www.euro.who.int/en/health-topics/communicable-diseas... . Last accessed October 2015.

[8] European Medicines Agency (2015). Edurant: EPAR - Product Information. [Online]. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_... . Last accessed October 2015.  

[9] Electronic Medicines Compendium (2015). Edurant 25 mg tablets. [Online]. Available at: http://www.medicines.org.uk/emc/medicine.... Last accessed October 2015.  

 

PHGB/HIV/1015/0006 

October 2015  

 

MEDIA CONTACT:

 

Ines Hammer 

+33-6-88-09-33-35 

IHAMMER@its.jnj.com

 

INVESTOR RELATIONS:

 

Louise Mehrotra 

Office: +1-732-524-6491

 

Lesley Fishman 

Office: +1-732-524-3922 

Photo:

http://photos.prnewswire.com/prnh/201403...

http://photos.prnewswire.com/prnh/20151020/278750-INFO

http://photos.prnewswire.com/prnh/20151020/278751-INFO

Contenido patrocinado